Last updated: 16 June 2019 at 6:51pm EST

Gregory Renard Jones Net Worth




The estimated Net Worth of Gregory Renard Jones is at least $1.28 Million dollars as of 11 August 2015. Gregory Jones owns over 2,500 units of Conmed stock worth over $1,127,477 and over the last 15 years Gregory sold CNMD stock worth over $156,380.

Gregory Jones CNMD stock SEC Form 4 insiders trading

Gregory has made over 10 trades of the Conmed stock since 2011, according to the Form 4 filled with the SEC. Most recently Gregory sold 2,500 units of CNMD stock worth $140,075 on 11 August 2015.

The largest trade Gregory's ever made was exercising 5,310 units of Conmed stock on 1 June 2014 worth over $389,595. On average, Gregory trades about 627 units every 38 days since 2009. As of 11 August 2015 Gregory still owns at least 15,367 units of Conmed stock.

You can see the complete history of Gregory Jones stock trades at the bottom of the page.



What's Gregory Jones's mailing address?

Gregory's mailing address filed with the SEC is C/O CONMED CORPORATION, 525 FRENCH ROAD, UTICA, NY, 13502.

Insiders trading at Conmed

Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti, and Dirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.



What does Conmed do?

conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500



Complete history of Gregory Jones stock trades at Conmed

Insider
Trans.
Transaction
Total value
Gregory Renard Jones
Vice President-Corporate QA/RA
Sale $140,075
11 Aug 2015
Gregory Renard Jones
Vice President-Corporate QA/RA
Option $280,171
1 Jun 2015
Gregory Renard Jones
Vice President-Corporate QA/RA
Option $238,419
1 Jun 2014
Gregory Renard Jones
Vice President-Corporate QA/RA
Sale $16,305
13 Aug 2013
Gregory Renard Jones
Vice President-Corporate QA/RA
Option $6,606
1 Aug 2013
Gregory Renard Jones
Vice President-Corporate QA/RA
Option $148,514
1 Jun 2013
Gregory Renard Jones
Vice President-Corporate QA/RA
Option $5,376
1 Aug 2012
Gregory Renard Jones
Vice President-Corporate QA/RA
Option $96,794
1 Jun 2012
Gregory Renard Jones
Vice President-Corporate QA/RA
Option $5,204
1 Aug 2011
Gregory Renard Jones
Vice President-Corporate QA/RA
Option $80,403
1 Jun 2011


Conmed executives and stock owners

Conmed executives and other stock owners filed with the SEC include: